Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Clinical Ophthalmology (Auckland, N.Z.)|April 19, 2011
The effect of stromal hydration on surgical outcomes for cataract patients who received a hydrogel ocular bandageThomas R WaltersClinical Ophthalmology (Auckland, N.Z.)|June 1, 2018
An ex vivo human aqueous humor-concentration comparison of two commercial bromfenac formulationsThomas R Walters, Robert J Smyth-Medina, Paul C CockrumOphthalmology|September 12, 2013
Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trialsThomas R Walters, Damien F Goldberg, James H Peace, et al.Journal of Cataract and Refractive Surgery|December 2, 2025
A Dose-Selection Study of Clobetasol Propionate Ophthalmic Suspension that Evaluated Inflammation and Pain after Cataract SurgeryJeffrey Levenson, Thomas R Walters, Joseph Martel, et al.Therapeutic Delivery|March 15, 2021
Mydriasis with micro-array print touch-free tropicamide-phenylephrine fixed combination MIST: pooled randomized Phase III trialsDavid L Wirta, Thomas R Walters, William J Flynn, et al.Clinical Ophthalmology (Auckland, N.Z.)|April 28, 2021
Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large SampleRobert Lehmann, Andrew Maxwell, David M Lubeck, et al.Survey of Ophthalmology|March 16, 2004
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trialThomas R Walters, Harvey B DuBiner, Susan P Carpenter, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 25, 2005
Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertensionE Randy Craven, Thomas R Walters, Robert Williams, et al.Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2022
Rotational Stability of the Clareon Monofocal Aspheric Hydrophobic Acrylic Intraocular Lens 6 Months After ImplantationThomas R Walters, Robert Lehmann, Andrew Moyes, et al.Patient Preference and Adherence|March 24, 2017
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative surveyJoseph P Gira, Reginald Sampson, Steven M Silverstein, et al.Pageof 2